Multilayer Paper Analytical Device for Low-Cost Pharmaceutical Quality Control
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is a need for a low-cost, user-friendly method to detect low-quality pharmaceutical products and dietary supplements, particularly in developing countries where manufacturing and selling such products is lucrative and often goes undetected, and there is a lack of effective post-market surveillance due to high testing costs and expertise requirements.
Innovation Solution
A Paper Analytical Device (PAD) is developed, comprising assay regions with reagents housed in rupturable vessels and a binder agent, allowing for easy activation and fluid communication, which can detect chemical components indicative of low-quality products, including iodine levels in iodized salt, using a hydrophilic substrate and hydrophobic material for fluid path creation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If traditional analytical methods are used for detecting pharmaceutical quality, then measurement precision can be achieved, but device complexity and cost increase significantly
Solution Approach 1:
The device is segmented into distinct functional zones on a paper substrate: sample application zone, reagent zones (with vessels containing different reagents), control zones, and reading zones. This segmentation allows complex analytical functionality to be distributed across simple, discrete regions, maintaining detection accuracy while reducing overall device complexity.
Solution Approach 2:
A paper-based analytical device serves as an intermediary between the pharmaceutical sample and the detection system. The paper substrate with integrated reagents and fluid paths mediates the chemical reactions, transforming complex pharmaceutical analysis into simple colorimetric changes that can be read by basic optical devices, thus reducing the complexity of the complete analytical system.
2Measurement precision
If comprehensive pharmaceutical analysis is performed, then measurement precision improves, but ease of operation deteriorates due to expertise requirements
Solution Approach 1:
The device performs self-service through pre-integrated reagents in rupturable vessels, pre-defined fluid paths on the paper substrate, and built-in control zones that automatically validate the testing process. The user simply applies the sample and waits for results, while the device automatically manages reagent delivery, reaction conditions, and quality control, eliminating the need for specialized pharmaceutical analysis expertise.
Solution Approach 2:
All necessary reagents, fluid paths, and control mechanisms are prepared in advance during device manufacturing. The reagents are pre-loaded into sealed vessels, the paper substrate is pre-patterned with hydrophobic barriers and capillary channels, and control zones are pre-positioned. This preliminary preparation transforms a complex analytical procedure into a simple plug-and-play operation for the end user.
3Measurement precision
If multiple chemical components are detected, then measurement precision and quality control improve, but device complexity increases
Solution Approach 1:
The paper-based device is designed with universal multi-functionality, incorporating multiple reagent vessels, assay regions, and detection zones on a single integrated substrate. Different reagents can detect various chemical components (active ingredients, excipients, contaminants) simultaneously, allowing comprehensive quality control of pharmaceutical products without requiring multiple separate devices or complex instrumentation.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The PAD provides a reliable, inexpensive, and easy-to-use method for detecting low-quality pharmaceuticals and dietary supplements, enabling consistent analysis of multiple chemical components, including active ingredients and excipients, and iodine levels, thereby addressing the quality control challenges in developing countries.
Implementation Method 1
a non-chemically interfering binder agent disposed between the assay regions and vessels. The vessels are arranged to be adjacent to the assaying regions with the binding agent configured for providing a fluid path such that rupture of a vessel wall establishes fluid communication between the one or more reagents released by the ruptured vessel wall and the corresponding assay region along the fluid path
Implementation Method 2
detecting color change of reagent analyte interaction
Data Source
AI summary
A multilayer Paper Analytical Device (PAD) and method for detection of a low quality pharmaceutical or dietary supplement product. The multilayer PAD includes one or more assay regions, one or more reagent vessels in registry with the assay region(s), and a non-chemically interfering binder agent disposed between the assay regions and vessels, so that rupture of the vessels enables the reagents to wet the assaying regions and contact a sample of a suspected low quality pharmaceutical product or dietary supplement for testing thereof. A kit is also provided for detection of a low quality pharmaceutical or dietary supplement product, the kit including a multilayer PAD and instructions for using the kit.